Related references
Note: Only part of the references are listed.Cheminformatics Analysis of Assertions Mined from Literature That Describe Drug-Induced Liver Injury in Different Species
Denis Fourches et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2010)
Important Elements for the Diagnosis of Drug-Induced Liver Injury
Vijay K. Agarwal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Acetaminophen Dosing of Humans Results in Blood Transcriptome and Metabolome Changes Consistent with Impaired Oxidative Phosphorylation
Rick D. Fannin et al.
HEPATOLOGY (2010)
Mitochondrial Superoxide Dismutase and Glutathione Peroxidase in Idiosyncratic Drug-Induced Liver Injury
M. Isabel Lucena et al.
HEPATOLOGY (2010)
Mitochondrial and Immunoallergic Injury Increase Risk of Positive Drug Rechallenge After Drug-Induced Liver Injury: A Systematic Review
Christine M. Hunt
HEPATOLOGY (2010)
Standardization of nomenclature and causality assessment in drug-induced liver injury: Summary of a clinical research workshop
Robert J. Fontana et al.
HEPATOLOGY (2010)
A Role for the Pregnane X Receptor in Flucloxacillin-Induced Liver Injury
Elise Andrews et al.
HEPATOLOGY (2010)
Polymerase γ Gene POLG Determines the Risk of Sodium Valproate-Induced Liver Toxicity
Joanna D. Stewart et al.
HEPATOLOGY (2010)
Liver disease associated with canalicular transport defects: Current and future therapies
Janneke M. Stapelbroek et al.
JOURNAL OF HEPATOLOGY (2010)
A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury
Jonathan B. Singer et al.
NATURE GENETICS (2010)
Pharmacokinetics of Acetaminophen-Protein Adducts in Adults with Acetaminophen Overdose and Acute Liver Failure
Laura P. James et al.
DRUG METABOLISM AND DISPOSITION (2009)
S1590 Immuno-Allergic (I-a) Manifestations of Drug-Induced Liver Injury (DILI) in the USA. Results from the Prospective Study of the DILI Network
Herbert L. Bonkovsky et al.
GASTROENTEROLOGY (2009)
Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans
Alison H. Harrill et al.
GENOME RESEARCH (2009)
Expression of Organic Cation Transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) Is Affected by Genetic Factors and Cholestasis in Human Liver
Anne T. Nies et al.
HEPATOLOGY (2009)
HLA-B☆5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
Ann K. Daly et al.
NATURE GENETICS (2009)
Case series of liver failure associated with rosiglitazone and pioglitazone
James S. Floyd et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Drug-induced liver injury following positive drug rechallenge
Julie I. Papay et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2009)
Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part C: Use of QSAR and an expert system for the estimation of the mechanism of action of drug-induced hepatobiliary and urinary tract toxicities
Edwin J. Matthews et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2009)
Biomarkers for the Diagnosis and Management of Drug-Induced Liver Injury
Paul B. Watkins
SEMINARS IN LIVER DISEASE (2009)
Immunoallergic Drug-Induced Liver Injury in Humans
Jack Uetrecht
SEMINARS IN LIVER DISEASE (2009)
Role of Mitochondria in Drug-Induced Cholestatic Injury
George E. N. Kass et al.
CLINICS IN LIVER DISEASE (2008)
Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-induced Liver Injury in the United States
Naga Chalasani et al.
GASTROENTEROLOGY (2008)
Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: Search for signals
Craig Lammert et al.
HEPATOLOGY (2008)
Critical role of CD44 in hepatotoxin-mediated liver injury
Kiminori Kimura et al.
JOURNAL OF HEPATOLOGY (2008)
Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis
A. Kindmark et al.
PHARMACOGENOMICS JOURNAL (2008)
Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury
Yi-Shin Huang et al.
JOURNAL OF HEPATOLOGY (2007)
Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury
Carmen Lang et al.
PHARMACOGENETICS AND GENOMICS (2007)
Retrospective analysis of transient elevations in alanine aminotransferase during long-term treatment with acetaminophen in osteoarthritis clinical trials
Edwin K. Kuffner et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Hepatobiliary transporters and drug-induced cholestasis
Christiane Pauli-Magnus et al.
HEPATOLOGY (2006)
Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily - A randomized controlled trial
Paul B. Watkins et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Drug-induced liver injury: Summary of a single topic - Clinical research conference
PB Watkins et al.
HEPATOLOGY (2006)
Measurement of serum acetaminophen-protein adducts in patients with acute liver failure
TJ Davern et al.
GASTROENTEROLOGY (2006)
Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study
AM Larson et al.
HEPATOLOGY (2005)
Effect of rosiglitazone on serum liver biochemistries in diabetic patients with normal and elevated baseline liver enzymes
N Chalasani et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Diagnosis of drug hypersensitivity: lymphocyte transformation test and cytokines
HF Merk
TOXICOLOGY (2005)
Role of metabolism in drug-induced idiosyncratic hepatotoxicity
JL Walgren et al.
CRITICAL REVIEWS IN TOXICOLOGY (2005)
Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in Japanese type 2 diabetic patients
T Hamanishi et al.
DIABETES (2004)
The lymphocyte transformation test in the diagnosis of drug hypersensitivity
WJ Pichler et al.
ALLERGY (2004)
Adverse hepatic drug reactions: inflammatory episodes as consequence and contributor
PE Ganey et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2004)
HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease
RJ Andrade et al.
HEPATOLOGY (2004)
Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States
G Ostapowicz et al.
ANNALS OF INTERNAL MEDICINE (2002)
Incidence of drug-induced hepatic injuries: A French population-based study
C Sgro et al.
HEPATOLOGY (2002)
Co-amoxiclav jaundice: clinical and histological features and HLA class II association
J O'Donohue et al.
GUT (2000)
Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity
TN Kakuda
CLINICAL THERAPEUTICS (2000)
Share Paper
